ID   PAK3_HUMAN              Reviewed;         559 AA.
AC   O75914; A8K389; B1GX77; B1GX78; B1GX79; Q5JWX1; Q5JWX2; Q7Z2D6;
AC   Q7Z2E4; Q7Z3Z8; Q8WWK5; Q8WX23; Q9P0J8;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2004, sequence version 2.
DT   10-MAY-2017, entry version 178.
DE   RecName: Full=Serine/threonine-protein kinase PAK 3;
DE            EC=2.7.11.1;
DE   AltName: Full=Beta-PAK;
DE   AltName: Full=Oligophrenin-3;
DE   AltName: Full=p21-activated kinase 3;
DE            Short=PAK-3;
GN   Name=PAK3; Synonyms=OPHN3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND INVOLVEMENT IN MRX30.
RX   PubMed=9731525; DOI=10.1038/1675;
RA   Allen K.M., Gleeson J.G., Bagrodia S., Partington M.W.,
RA   Macmillan J.C., Cerione R.A., Mulley J.C., Walsh C.A.;
RT   "PAK3 mutation in nonsyndromic X-linked mental retardation.";
RL   Nat. Genet. 20:25-30(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Adrenal gland;
RA   Jiang C., Gu J., Fu S., Ren S., Gu Y., Huang Q., Dong H., Yu Y.,
RA   Fu G., Wang Y., Chen Z., Han Z.;
RT   "A novel gene expressed in the human adrenal gland.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=12777533; DOI=10.1093/molbev/msg134;
RA   Kitano T., Schwarz C., Nickel B., Paeaebo S.;
RT   "Gene diversity patterns at 10 X-chromosomal loci in humans and
RT   chimpanzees.";
RL   Mol. Biol. Evol. 20:1281-1289(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 3 AND 4).
RC   TISSUE=Brain;
RX   PubMed=18507705; DOI=10.1111/j.1471-4159.2008.05474.x;
RA   Kreis P., Rousseau V., Thevenot E., Combeau G., Barnier J.V.;
RT   "The four mammalian splice variants encoded by the p21-activated
RT   kinase 3 gene have different biological properties.";
RL   J. Neurochem. 106:1184-1197(2008).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   AUTOPHOSPHORYLATION.
RX   PubMed=11278486; DOI=10.1074/jbc.M009316200;
RA   Chong C., Tan L., Lim L., Manser E.;
RT   "The mechanism of PAK activation. Autophosphorylation events in both
RT   regulatory and kinase domains control activity.";
RL   J. Biol. Chem. 276:17347-17353(2001).
RN   [9]
RP   INTERACTION WITH ARHGEF6 AND ARHGEF7.
RX   PubMed=11741931; DOI=10.1074/jbc.M107704200;
RA   Feng Q., Albeck J.G., Cerione R.A., Yang W.;
RT   "Regulation of the Cool/Pix proteins: key binding partners of the
RT   Cdc42/Rac targets, the p21-activated kinases.";
RL   J. Biol. Chem. 277:5644-5650(2002).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=12890786;
RA   McPhie D.L., Coopersmith R., Hines-Peralta A., Chen Y., Ivins K.J.,
RA   Manly S.P., Kozlowski M.R., Neve K.A., Neve R.L.;
RT   "DNA synthesis and neuronal apoptosis caused by familial Alzheimer
RT   disease mutants of the amyloid precursor protein are mediated by the
RT   p21 activated kinase PAK3.";
RL   J. Neurosci. 23:6914-6927(2003).
RN   [11]
RP   NEDDYLATION.
RX   PubMed=20596523; DOI=10.1371/journal.pone.0011332;
RA   Del Rincon S.V., Rogers J., Widschwendter M., Sun D., Sieburg H.B.,
RA   Spruck C.;
RT   "Development and validation of a method for profiling post-
RT   translational modification activities using protein microarrays.";
RL   PLoS ONE 5:E11332-E11332(2010).
RN   [12]
RP   FUNCTION IN PHOSPHORYLATION OF MAPK4 AND MAPK6.
RX   PubMed=21177870; DOI=10.1074/jbc.M110.181529;
RA   Deleris P., Trost M., Topisirovic I., Tanguay P.L., Borden K.L.,
RA   Thibault P., Meloche S.;
RT   "Activation loop phosphorylation of ERK3/ERK4 by group I p21-activated
RT   kinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated protein
RT   kinase 5 signaling pathway.";
RL   J. Biol. Chem. 286:6470-6478(2011).
RN   [13]
RP   REVIEW ON FUNCTION.
RX   PubMed=19036346; DOI=10.1016/j.cellsig.2008.11.001;
RA   Kreis P., Barnier J.V.;
RT   "PAK signalling in neuronal physiology.";
RL   Cell. Signal. 21:384-393(2009).
RN   [14]
RP   VARIANT MRX30 CYS-67.
RX   PubMed=10946356;
RX   DOI=10.1002/1096-8628(20000814)93:4<294::AID-AJMG8>3.0.CO;2-F;
RA   Bienvenu T., des Portes V., McDonell N., Carrie A., Zemni R.,
RA   Couvert P., Ropers H.-H., Moraine C., van Bokhoven H., Fryns J.-P.,
RA   Allen K., Walsh C.A., Boue J., Kahn A., Chelly J., Beldjord C.;
RT   "Missense mutation in PAK3, R67C, causes X-linked nonspecific mental
RT   retardation.";
RL   Am. J. Med. Genet. 93:294-298(2000).
RN   [15]
RP   VARIANT MRX30 GLU-380.
RX   PubMed=12884430; DOI=10.1002/ajmg.a.20131;
RA   Gedeon A.K., Nelson J., Gecz J., Mulley J.C.;
RT   "X-linked mild non-syndromic mental retardation with neuropsychiatric
RT   problems and the missense mutation A365E in PAK3.";
RL   Am. J. Med. Genet. A 120:509-517(2003).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-440.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine protein kinase that plays a role in a
CC       variety of different signaling pathways including cytoskeleton
CC       regulation, cell migration, or cell cycle regulation. Plays a role
CC       in dendrite spine morphogenesis as well as synapse formation and
CC       plasticity. Acts as downstream effector of the small GTPases CDC42
CC       and RAC1. Activation by the binding of active CDC42 and RAC1
CC       results in a conformational change and a subsequent
CC       autophosphorylation on several serine and/or threonine residues.
CC       Phosphorylates MAPK4 and MAPK6 and activates the downstream target
CC       MAPKAPK5, a regulator of F-actin polymerization and cell
CC       migration. Additionally, phosphorylates TNNI3/troponin I to
CC       modulate calcium sensitivity and relaxation kinetics of thin
CC       myofilaments. May also be involved in early neuronal development.
CC       {ECO:0000269|PubMed:21177870}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC   -!- ENZYME REGULATION: Activated by binding small G proteins. Binding
CC       of GTP-bound CDC42 or RAC1 to the autoregulatory region releases
CC       monomers from the autoinhibited dimer, enables phosphorylation of
CC       Thr-436 and allows the kinase domain to adopt an active structure
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts tightly with GTP-bound but not GDP-bound
CC       CDC42/p21 and RAC1. Shows highly specific binding to the SH3
CC       domains of phospholipase C-gamma and of adapter protein NCK.
CC       Interacts with the C-terminal of APP (By similarity). Interacts
CC       with ARHGEF6 and ARHGEF7. {ECO:0000250,
CC       ECO:0000269|PubMed:11741931}.
CC   -!- INTERACTION:
CC       P60953-2:CDC42; NbExp=2; IntAct=EBI-3389553, EBI-287394;
CC       P63000:RAC1; NbExp=2; IntAct=EBI-3389553, EBI-413628;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=PAK3b;
CC         IsoId=O75914-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75914-2; Sequence=VSP_010242;
CC       Name=3; Synonyms=PAK3cb;
CC         IsoId=O75914-3; Sequence=VSP_041839;
CC       Name=4; Synonyms=PAK3c;
CC         IsoId=O75914-4; Sequence=VSP_041840;
CC   -!- TISSUE SPECIFICITY: Restricted to the nervous system. Highly
CC       expressed in postmitotic neurons of the developing and postnatal
CC       cerebral cortex and hippocampus. {ECO:0000269|PubMed:12890786}.
CC   -!- PTM: Autophosphorylated when activated by CDC42/p21.
CC   -!- PTM: Neddylated. {ECO:0000269|PubMed:20596523}.
CC   -!- DISEASE: Mental retardation, X-linked 30 (MRX30) [MIM:300558]: A
CC       disorder characterized by significantly below average general
CC       intellectual functioning associated with impairments in adaptive
CC       behavior and manifested during the developmental period.
CC       Intellectual deficiency is the only primary symptom of non-
CC       syndromic X-linked mental retardation, while syndromic mental
CC       retardation presents with associated physical, neurological and/or
CC       psychiatric manifestations. {ECO:0000269|PubMed:10946356,
CC       ECO:0000269|PubMed:12884430, ECO:0000269|PubMed:9731525}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF068864; AAC36097.1; -; mRNA.
DR   EMBL; AF155651; AAF67008.1; -; mRNA.
DR   EMBL; AB102659; BAC81128.1; -; mRNA.
DR   EMBL; AB102251; BAC80750.1; -; Genomic_DNA.
DR   EMBL; AB102252; BAC80751.1; -; Genomic_DNA.
DR   EMBL; AB102253; BAC80752.1; -; Genomic_DNA.
DR   EMBL; AB102254; BAC80753.1; -; Genomic_DNA.
DR   EMBL; AB102255; BAC80754.1; -; Genomic_DNA.
DR   EMBL; AB102256; BAC80755.1; -; Genomic_DNA.
DR   EMBL; AB102257; BAC80756.1; -; Genomic_DNA.
DR   EMBL; AB102258; BAC80757.1; -; Genomic_DNA.
DR   EMBL; AB102259; BAC80758.1; -; Genomic_DNA.
DR   EMBL; AB102260; BAC80759.1; -; Genomic_DNA.
DR   EMBL; AB102261; BAC80760.1; -; Genomic_DNA.
DR   EMBL; AB102262; BAC80761.1; -; Genomic_DNA.
DR   EMBL; AB102263; BAC80762.1; -; Genomic_DNA.
DR   EMBL; AB102264; BAC80763.1; -; Genomic_DNA.
DR   EMBL; AB102265; BAC80764.1; -; Genomic_DNA.
DR   EMBL; AB102266; BAC80765.1; -; Genomic_DNA.
DR   EMBL; AB102267; BAC80766.1; -; Genomic_DNA.
DR   EMBL; AB102268; BAC80767.1; -; Genomic_DNA.
DR   EMBL; AB102269; BAC80768.1; -; Genomic_DNA.
DR   EMBL; AB102270; BAC80769.1; -; Genomic_DNA.
DR   EMBL; AB102281; BAC80780.1; -; Genomic_DNA.
DR   EMBL; AB102282; BAC80781.1; -; Genomic_DNA.
DR   EMBL; AB102283; BAC80782.1; -; Genomic_DNA.
DR   EMBL; AB102284; BAC80783.1; -; Genomic_DNA.
DR   EMBL; AB102285; BAC80784.1; -; Genomic_DNA.
DR   EMBL; AB102286; BAC80785.1; -; Genomic_DNA.
DR   EMBL; AB102287; BAC80786.1; -; Genomic_DNA.
DR   EMBL; AB102288; BAC80787.1; -; Genomic_DNA.
DR   EMBL; AB102289; BAC80788.1; -; Genomic_DNA.
DR   EMBL; AB102290; BAC80789.1; -; Genomic_DNA.
DR   EMBL; AB102291; BAC80790.1; -; Genomic_DNA.
DR   EMBL; AB102292; BAC80791.1; -; Genomic_DNA.
DR   EMBL; AB102293; BAC80792.1; -; Genomic_DNA.
DR   EMBL; AB102294; BAC80793.1; -; Genomic_DNA.
DR   EMBL; AB102295; BAC80794.1; -; Genomic_DNA.
DR   EMBL; AB102296; BAC80795.1; -; Genomic_DNA.
DR   EMBL; AB102297; BAC80796.1; -; Genomic_DNA.
DR   EMBL; AB102298; BAC80797.1; -; Genomic_DNA.
DR   EMBL; AB102299; BAC80798.1; -; Genomic_DNA.
DR   EMBL; AB102300; BAC80799.1; -; Genomic_DNA.
DR   EMBL; AM943850; CAQ16016.1; -; mRNA.
DR   EMBL; AM943851; CAQ16017.1; -; mRNA.
DR   EMBL; AM943852; CAQ16018.1; -; mRNA.
DR   EMBL; AK290504; BAF83193.1; -; mRNA.
DR   EMBL; AL356578; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL357774; CAI40843.1; -; Genomic_DNA.
DR   EMBL; AL031117; CAI40843.1; JOINED; Genomic_DNA.
DR   EMBL; AL117326; CAI40843.1; JOINED; Genomic_DNA.
DR   EMBL; AL357774; CAI40844.1; -; Genomic_DNA.
DR   EMBL; AL031117; CAI40844.1; JOINED; Genomic_DNA.
DR   EMBL; AL117326; CAI40844.1; JOINED; Genomic_DNA.
DR   EMBL; AL031117; CAI43157.1; -; Genomic_DNA.
DR   EMBL; AL117326; CAI43157.1; JOINED; Genomic_DNA.
DR   EMBL; AL357774; CAI43157.1; JOINED; Genomic_DNA.
DR   EMBL; AL031117; CAI43158.1; -; Genomic_DNA.
DR   EMBL; AL117326; CAI43158.1; JOINED; Genomic_DNA.
DR   EMBL; AL357774; CAI43158.1; JOINED; Genomic_DNA.
DR   EMBL; AL117326; CAI43167.1; -; Genomic_DNA.
DR   EMBL; AL031117; CAI43167.1; JOINED; Genomic_DNA.
DR   EMBL; AL357774; CAI43167.1; JOINED; Genomic_DNA.
DR   EMBL; AL117326; CAI43168.1; -; Genomic_DNA.
DR   EMBL; AL031117; CAI43168.1; JOINED; Genomic_DNA.
DR   EMBL; AL357774; CAI43168.1; JOINED; Genomic_DNA.
DR   EMBL; CH471120; EAX02654.1; -; Genomic_DNA.
DR   CCDS; CCDS14554.1; -. [O75914-2]
DR   CCDS; CCDS48151.1; -. [O75914-3]
DR   CCDS; CCDS48152.1; -. [O75914-4]
DR   CCDS; CCDS48153.1; -. [O75914-1]
DR   RefSeq; NP_001121638.1; NM_001128166.2. [O75914-2]
DR   RefSeq; NP_001121639.1; NM_001128167.2. [O75914-2]
DR   RefSeq; NP_001121640.1; NM_001128168.2. [O75914-3]
DR   RefSeq; NP_001121644.1; NM_001128172.2. [O75914-4]
DR   RefSeq; NP_001121645.1; NM_001128173.2. [O75914-1]
DR   RefSeq; NP_001311254.1; NM_001324325.1. [O75914-2]
DR   RefSeq; NP_001311255.1; NM_001324326.1. [O75914-2]
DR   RefSeq; NP_001311256.1; NM_001324327.1. [O75914-1]
DR   RefSeq; NP_001311257.1; NM_001324328.1. [O75914-1]
DR   RefSeq; NP_001311258.1; NM_001324329.1. [O75914-1]
DR   RefSeq; NP_001311259.1; NM_001324330.1. [O75914-2]
DR   RefSeq; NP_001311260.1; NM_001324331.1. [O75914-2]
DR   RefSeq; NP_001311261.1; NM_001324332.1. [O75914-2]
DR   RefSeq; NP_001311262.1; NM_001324333.1. [O75914-1]
DR   RefSeq; NP_001311263.1; NM_001324334.1. [O75914-2]
DR   RefSeq; NP_002569.1; NM_002578.4. [O75914-2]
DR   RefSeq; XP_016885046.1; XM_017029557.1. [O75914-1]
DR   RefSeq; XP_016885050.1; XM_017029561.1. [O75914-2]
DR   RefSeq; XP_016885052.1; XM_017029563.1. [O75914-3]
DR   UniGene; Hs.593599; -.
DR   UniGene; Hs.655757; -.
DR   UniGene; Hs.656789; -.
DR   ProteinModelPortal; O75914; -.
DR   SMR; O75914; -.
DR   BioGrid; 111099; 8.
DR   IntAct; O75914; 4.
DR   MINT; MINT-3001915; -.
DR   STRING; 9606.ENSP00000353864; -.
DR   BindingDB; O75914; -.
DR   ChEMBL; CHEMBL2999; -.
DR   GuidetoPHARMACOLOGY; 2135; -.
DR   iPTMnet; O75914; -.
DR   PhosphoSitePlus; O75914; -.
DR   BioMuta; PAK3; -.
DR   PaxDb; O75914; -.
DR   PeptideAtlas; O75914; -.
DR   PRIDE; O75914; -.
DR   DNASU; 5063; -.
DR   Ensembl; ENST00000262836; ENSP00000262836; ENSG00000077264. [O75914-1]
DR   Ensembl; ENST00000360648; ENSP00000353864; ENSG00000077264. [O75914-3]
DR   Ensembl; ENST00000372007; ENSP00000361077; ENSG00000077264. [O75914-2]
DR   Ensembl; ENST00000372010; ENSP00000361080; ENSG00000077264. [O75914-1]
DR   Ensembl; ENST00000417227; ENSP00000389172; ENSG00000077264. [O75914-4]
DR   Ensembl; ENST00000425146; ENSP00000401982; ENSG00000077264. [O75914-2]
DR   Ensembl; ENST00000446737; ENSP00000410853; ENSG00000077264. [O75914-2]
DR   Ensembl; ENST00000518291; ENSP00000428921; ENSG00000077264. [O75914-3]
DR   Ensembl; ENST00000519681; ENSP00000429113; ENSG00000077264. [O75914-4]
DR   GeneID; 5063; -.
DR   KEGG; hsa:5063; -.
DR   UCSC; uc004eoz.3; human. [O75914-1]
DR   CTD; 5063; -.
DR   DisGeNET; 5063; -.
DR   GeneCards; PAK3; -.
DR   HGNC; HGNC:8592; PAK3.
DR   HPA; HPA044791; -.
DR   HPA; HPA060219; -.
DR   MalaCards; PAK3; -.
DR   MIM; 300142; gene.
DR   MIM; 300558; phenotype.
DR   neXtProt; NX_O75914; -.
DR   OpenTargets; ENSG00000077264; -.
DR   Orphanet; 777; X-linked non-syndromic intellectual disability.
DR   PharmGKB; PA32919; -.
DR   eggNOG; KOG0578; Eukaryota.
DR   eggNOG; ENOG410XP4K; LUCA.
DR   GeneTree; ENSGT00860000133680; -.
DR   HOGENOM; HOG000234202; -.
DR   HOVERGEN; HBG108518; -.
DR   InParanoid; O75914; -.
DR   KO; K05733; -.
DR   OMA; XKPPAPP; -.
DR   OrthoDB; EOG091G04H8; -.
DR   PhylomeDB; O75914; -.
DR   TreeFam; TF105351; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   Reactome; R-HSA-202433; Generation of second messenger molecules.
DR   Reactome; R-HSA-389359; CD28 dependent Vav1 pathway.
DR   Reactome; R-HSA-3928664; Ephrin signaling.
DR   Reactome; R-HSA-399954; Sema3A PAK dependent Axon repulsion.
DR   Reactome; R-HSA-428540; Activation of Rac.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   Reactome; R-HSA-5621575; CD209 (DC-SIGN) signaling.
DR   Reactome; R-HSA-5627123; RHO GTPases activate PAKs.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   SignaLink; O75914; -.
DR   SIGNOR; O75914; -.
DR   ChiTaRS; PAK3; human.
DR   GeneWiki; PAK3; -.
DR   GenomeRNAi; 5063; -.
DR   PRO; PR:O75914; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000077264; -.
DR   ExpressionAtlas; O75914; baseline and differential.
DR   Genevisible; O75914; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005768; C:endosome; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004708; F:MAP kinase kinase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; EXP:Reactome.
DR   GO; GO:0017048; F:Rho GTPase binding; IEA:Ensembl.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0007409; P:axonogenesis; ISS:UniProtKB.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0016358; P:dendrite development; ISS:UniProtKB.
DR   GO; GO:0060997; P:dendritic spine morphogenesis; ISS:UniProtKB.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; IEA:Ensembl.
DR   GO; GO:2000573; P:positive regulation of DNA biosynthetic process; IEA:Ensembl.
DR   GO; GO:0010763; P:positive regulation of fibroblast migration; IEA:Ensembl.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0030833; P:regulation of actin filament polymerization; IDA:UniProtKB.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0050808; P:synapse organization; TAS:UniProtKB.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   CDD; cd01093; CRIB_PAK_like; 1.
DR   Gene3D; 3.90.810.10; -; 1.
DR   InterPro; IPR000095; CRIB_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR033923; PAK_BD.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00786; PBD; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00285; PBD; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50108; CRIB; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Allosteric enzyme; Alternative splicing; ATP-binding;
KW   Complete proteome; Cytoplasm; Developmental protein; Disease mutation;
KW   Kinase; Magnesium; Mental retardation; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; SH3-binding; Transferase;
KW   Ubl conjugation.
FT   CHAIN         1    559       Serine/threonine-protein kinase PAK 3.
FT                                /FTId=PRO_0000086469.
FT   DOMAIN       70     83       CRIB. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00057}.
FT   DOMAIN      283    534       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     289    297       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION       65    150       Autoregulatory region. {ECO:0000250}.
FT   REGION       65    123       GTPase-binding. {ECO:0000250}.
FT   REGION       84    282       Linker.
FT   COMPBIAS    187    201       Poly-Glu.
FT   ACT_SITE    402    402       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     312    312       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       2      2       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62829}.
FT   MOD_RES      50     50       Phosphoserine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     154    154       Phosphoserine; by autocatalysis.
FT                                {ECO:0000250}.
FT   MOD_RES     186    186       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61036}.
FT   MOD_RES     436    436       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000250}.
FT   VAR_SEQ      92    107       TPDLYGSQMCPGKLPE -> TNSPFQTSRPVTVASSQSEGK
FT                                M (in isoform 4).
FT                                {ECO:0000303|PubMed:18507705}.
FT                                /FTId=VSP_041840.
FT   VAR_SEQ      92     92       T -> TNSPFQTSRPVTVASSQSEGKM (in isoform
FT                                3). {ECO:0000303|PubMed:18507705}.
FT                                /FTId=VSP_041839.
FT   VAR_SEQ      93    107       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:9731525,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_010242.
FT   VARIANT      67     67       R -> C (in MRX30; dbSNP:rs121434612).
FT                                {ECO:0000269|PubMed:10946356}.
FT                                /FTId=VAR_023825.
FT   VARIANT     380    380       A -> E (in MRX30; dbSNP:rs121434613).
FT                                {ECO:0000269|PubMed:12884430}.
FT                                /FTId=VAR_023826.
FT   VARIANT     440    440       T -> S (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_046764.
FT   CONFLICT     32     32       S -> F (in Ref. 2; AAF67008).
FT                                {ECO:0000305}.
FT   CONFLICT     36     36       P -> S (in Ref. 2; AAF67008).
FT                                {ECO:0000305}.
FT   CONFLICT     73     73       P -> S (in Ref. 2; AAF67008).
FT                                {ECO:0000305}.
FT   CONFLICT    106    107       PE -> SL (in Ref. 2; AAF67008).
FT                                {ECO:0000305}.
FT   CONFLICT    123    123       T -> P (in Ref. 2; AAF67008).
FT                                {ECO:0000305}.
FT   CONFLICT    127    130       QKKN -> PEEE (in Ref. 2; AAF67008).
FT                                {ECO:0000305}.
FT   CONFLICT    134    137       VLDV -> CSRC (in Ref. 2; AAF67008).
FT                                {ECO:0000305}.
FT   CONFLICT    146    148       TVN -> PVT (in Ref. 2; AAF67008).
FT                                {ECO:0000305}.
FT   CONFLICT    175    175       T -> P (in Ref. 2; AAF67008).
FT                                {ECO:0000305}.
SQ   SEQUENCE   559 AA;  62310 MW;  BC39AEC6F0A5478B CRC64;
     MSDGLDNEEK PPAPPLRMNS NNRDSSALNH SSKPLPMAPE EKNKKARLRS IFPGGGDKTN
     KKKEKERPEI SLPSDFEHTI HVGFDAVTGE FTPDLYGSQM CPGKLPEGIP EQWARLLQTS
     NITKLEQKKN PQAVLDVLKF YDSKETVNNQ KYMSFTSGDK SAHGYIAAHP SSTKTASEPP
     LAPPVSEEED EEEEEEEDEN EPPPVIAPRP EHTKSIYTRS VVESIASPAV PNKEVTPPSA
     ENANSSTLYR NTDRQRKKSK MTDEEILEKL RSIVSVGDPK KKYTRFEKIG QGASGTVYTA
     LDIATGQEVA IKQMNLQQQP KKELIINEIL VMRENKNPNI VNYLDSYLVG DELWVVMEYL
     AGGSLTDVVT ETCMDEGQIA AVCRECLQAL DFLHSNQVIH RDIKSDNILL GMDGSVKLTD
     FGFCAQITPE QSKRSTMVGT PYWMAPEVVT RKAYGPKVDI WSLGIMAIEM VEGEPPYLNE
     NPLRALYLIA TNGTPELQNP ERLSAVFRDF LNRCLEMDVD RRGSAKELLQ HPFLKLAKPL
     SSLTPLIIAA KEAIKNSSR
//
